144 related articles for article (PubMed ID: 15850005)
1. High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma.
Cotesta D; Caliumi C; Alò P; Petramala L; Reale MG; Masciangelo R; Signore A; Cianci R; D'Erasmo E; Letizia C
Tumori; 2005; 91(1):53-8. PubMed ID: 15850005
[TBL] [Abstract][Full Text] [Related]
2. Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumors.
Bernini G; Moretti A; Fontana V; Orlandini C; Miccoli P; Berti P; Basolo F; Faviana P; Bardini M; Salvetti A
Eur J Endocrinol; 2004 Aug; 151(2):215-22. PubMed ID: 15296477
[TBL] [Abstract][Full Text] [Related]
3. Plasma and tissue chromogranin in patients with adrenocortical adenomas.
Bernini GP; Moretti A; Borgioli M; Bardini M; Miccoli P; Berti P; Basolo F; Faviana P; Birindelli R; Salvetti A
J Endocrinol Invest; 2004 Oct; 27(9):821-5. PubMed ID: 15648545
[TBL] [Abstract][Full Text] [Related]
4. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
5. Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass.
Unger N; Hinrichs J; Deutschbein T; Schmidt H; Walz MK; Mann K; Petersenn S
Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):494-500. PubMed ID: 22696168
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A as serum marker of pituitary adenomas.
Gussi IL; Young J; Baudin E; Bidart JM; Chanson P
Clin Endocrinol (Oxf); 2003 Nov; 59(5):644-8. PubMed ID: 14616890
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Václavíková E; Widimský J
Physiol Res; 2017 Sep; 66(Suppl 3):S397-S408. PubMed ID: 28948824
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan.
Giovanella L; Squin N; Ghelfo A; Ceriani L
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):344-7. PubMed ID: 17043632
[TBL] [Abstract][Full Text] [Related]
9. Serum chromogranin-alpha immunoradiometric assay in the diagnosis of pheochromocytoma.
Giovanella L; Ceriani L
Int J Biol Markers; 2002; 17(2):130-4. PubMed ID: 12113580
[TBL] [Abstract][Full Text] [Related]
10. Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones.
Kimura N; Miura W; Noshiro T; Mizunashi K; Hanew K; Shimizu K; Watanabe T; Shibukawa S; Sohn HE; Abe K; Miura Y; Nagura H
Endocr J; 1997 Apr; 44(2):319-27. PubMed ID: 9228469
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactive adrenomedullin in human adrenal glands and adrenal tumors.
Satoh F; Takahashi K; Murakami O; Totsune K; Sone M; Ohneda M; Abe K; Miura Y; Mouri T
Cancer Detect Prev; 1997; 21(1):51-4. PubMed ID: 9043763
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
Stridsberg M; Husebye ES
Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129
[TBL] [Abstract][Full Text] [Related]
13. Plasma adrenomedullin concentrations in patients with adrenal pheochromocytoma.
Letizia C; De Toma G; Caliumi C; Cerci S; Massa R; Loria RD; Alo P; Marinoni EM; Diacinti D; D'Erasmo E
Horm Metab Res; 2001 May; 33(5):290-4. PubMed ID: 11440275
[TBL] [Abstract][Full Text] [Related]
14. Comparison of chromogranin A (CgA) levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males.
Glinicki P; Jeske W; Kapuścińska R; Zgliczyński W
Endokrynol Pol; 2015; 66(1):53-6. PubMed ID: 25754282
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A (CgA) in adrenal tumours.
Glinicki P; Jeske W; Bednarek-Papierska L; Kasperlik-Załuska A; Rosłonowska E; Gietka-Czernel M; Zgliczyński W
Endokrynol Pol; 2013; 64(5):358-62. PubMed ID: 24186592
[TBL] [Abstract][Full Text] [Related]
16. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
17. Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.
Guillemot J; Guérin M; Thouënnon E; Montéro-Hadjadje M; Leprince J; Lefebvre H; Klein M; Muresan M; Anouar Y; Yon L
PLoS One; 2014; 9(2):e88698. PubMed ID: 24523932
[TBL] [Abstract][Full Text] [Related]
18. Serum chromogranin-A assay in differential diagnosis of incidentally discovered adrenal masses.
Giovanella L
Anticancer Res; 2005; 25(3A):1547-50. PubMed ID: 16033058
[TBL] [Abstract][Full Text] [Related]
19. Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma.
Bílek R; Šafařík L; Ciprová V; Vlcek P; Lisá L
Physiol Res; 2008; 57 Suppl 1():S171-S179. PubMed ID: 18271679
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution.
Hsiao RJ; Neumann HP; Parmer RJ; Barbosa JA; O'Connor DT
Am J Med; 1990 Jun; 88(6):607-13. PubMed ID: 2189303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
